To study CK2-mediated SUZ12 phosphorylation in vivo, we used shRNAs to knock down the CK2 subunit α, α′, or β in an embryonic carcinoma cell line NT2/D1. The gene discussed is SUZ12; the disease is embryonal carcinoma.